Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Phosphoinositide 3-Kinase (PI3K) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitorsmarket, defines the market attractiveness level of Phosphoinositide 3-Kinase (PI3K) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Phosphoinositide 3-Kinase (PI3K) Inhibitors industry, describes the types of Phosphoinositide 3-Kinase (PI3K) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market and the development prospects and opportunities of Phosphoinositide 3-Kinase (PI3K) Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market in Chapter 13.
By Player:
Novartis AG
Gilead Sciences Inc
Bayer AG
Verastem Inc
TG Therapeutics Inc
By Type:
CLL-Chronic Iymphocytic Ieukemia
FL-Follicular Iymphoma
Other
By End-User:
Hospital
Research Institutes
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.2 United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.4 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.5 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.6 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
-
7.7 South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption (2017-2022)
8 Region and Country-wise Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast (2022-2028)
9 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CLL-Chronic Iymphocytic Ieukemia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global FL-Follicular Iymphoma Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CLL-Chronic Iymphocytic Ieukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global FL-Follicular Iymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
14.2 Gilead Sciences Inc
-
14.2.1 Gilead Sciences Inc Company Details
-
14.2.2 Gilead Sciences Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Sciences Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
14.3 Bayer AG
-
14.3.1 Bayer AG Company Details
-
14.3.2 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
14.4 Verastem Inc
-
14.4.1 Verastem Inc Company Details
-
14.4.2 Verastem Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Verastem Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
14.5 TG Therapeutics Inc
-
14.5.1 TG Therapeutics Inc Company Details
-
14.5.2 TG Therapeutics Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 TG Therapeutics Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Phosphoinositide 3-Kinase (PI3K) Inhibitors
-
Figure Phosphoinositide 3-Kinase (PI3K) Inhibitors Picture
-
Table Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption by Country (2017-2022)
-
Figure United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CLL-Chronic Iymphocytic Ieukemia Consumption and Growth Rate (2017-2022)
-
Figure Global FL-Follicular Iymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global CLL-Chronic Iymphocytic Ieukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FL-Follicular Iymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
Table Verastem Inc (Foundation Year, Company Profile and etc.)
-
Table Verastem Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Verastem Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
Table TG Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table TG Therapeutics Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table TG Therapeutics Inc Phosphoinositide 3-Kinase (PI3K) Inhibitors Product and Service
-
